FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783223403> ?p ?o ?g. }

• W2783223403 endingPage "24" @default.
• W2783223403 startingPage "9" @default.
• W2783223403 abstract "Intractable pruritus in hemodialysis patients can significantly decrease their quality of life and is also associated with poor vital prognosis. Although combined multiple causes of intractable pruritus in these patients have been identified, no existing treatments are proven to be sufficiently effective. We conducted a post-marketing surveillance to follow-up and assess the safety and efficacy of nalfurafine, a selective κ-opioid receptor agonist, for the treatment of intractable pruritus in patients undergoing hemodialysis.Hemodialysis patients with intractable pruritus from institutions in Japan who received oral nalfurafine hydrochloride between January 2010 and December 2013 were enrolled in the surveillance. Surveillance was completed in July 2015. Safety data during 1 year after nalfurafine treatment onset, and efficacy data of nalfurafine evaluating the first 12-week treatment period and the following period until 1 year after the initial dose of nalfurafine (using global assessment of the itch improvement by the physician, Visual Analog Scale, and the Shiratori's severity scores) were collected and analyzed.In total, 3,762 patients were analyzed for safety. Adverse drug reactions were experienced by 402/3,762 (10.69%) patients. The most frequent adverse drug reactions were insomnia (127/3,762 [3.38%] patients), constipation (34 [0.90%]), somnolence (32 [0.85%]), dizziness (23 [0.61%]), nausea (13 [0.35%]), and malaise (9 [0.24%]). No patients developed dependence on nalfurafine. Nalfurafine was effective in 82.50% (2,880/3,491) of patients during the first 12 weeks and in 84.95% (2,167/2,551) on treatment during the subsequent period until 1 year after nalfurafine treatment initiation. Statistically significant decreases were reported in the Visual Analog Scale and the Shiratori's severity scores (p<0.001).Oral nalfurafine hydrochloride (from 2.5 μg/day to a maximum of 5.0 μg/day) continues to be safe and effective for the treatment of intractable pruritus in hemodialysis patients in real-world clinical settings." @default.
• W2783223403 created "2018-01-26" @default.
• W2783223403 creator A5005089552 @default.
• W2783223403 creator A5078926521 @default.
• W2783223403 creator A5084574856 @default.
• W2783223403 date "2018-01-01" @default.
• W2783223403 modified "2023-10-14" @default.
• W2783223403 title "Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch^&reg;capsules 2.5 &mu;g) in 3,762 hemodialysis patients with intractable pruritus" @default.
• W2783223403 cites W1778955058 @default.
• W2783223403 cites W183201008 @default.
• W2783223403 cites W1972836142 @default.
• W2783223403 cites W1980831461 @default.
• W2783223403 cites W2019390260 @default.
• W2783223403 cites W2020850711 @default.
• W2783223403 cites W2021475268 @default.
• W2783223403 cites W2026359257 @default.
• W2783223403 cites W2034700992 @default.
• W2783223403 cites W2083248667 @default.
• W2783223403 cites W2083836840 @default.
• W2783223403 cites W2097033672 @default.
• W2783223403 cites W2108399692 @default.
• W2783223403 cites W2109822050 @default.
• W2783223403 cites W2130281254 @default.
• W2783223403 cites W2132959283 @default.
• W2783223403 cites W2135391751 @default.
• W2783223403 cites W2140123841 @default.
• W2783223403 cites W2160188055 @default.
• W2783223403 cites W2191862927 @default.
• W2783223403 cites W2218839371 @default.
• W2783223403 cites W2735601046 @default.
• W2783223403 cites W2912717193 @default.
• W2783223403 cites W4234293881 @default.
• W2783223403 doi "https://doi.org/10.2147/ijnrd.s145720" @default.
• W2783223403 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5774492" @default.
• W2783223403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29391822" @default.
• W2783223403 hasPublicationYear "2018" @default.
• W2783223403 type Work @default.
• W2783223403 sameAs 2783223403 @default.
• W2783223403 citedByCount "47" @default.
• W2783223403 countsByYear W27832234032018 @default.
• W2783223403 countsByYear W27832234032019 @default.
• W2783223403 countsByYear W27832234032020 @default.
• W2783223403 countsByYear W27832234032021 @default.
• W2783223403 countsByYear W27832234032022 @default.
• W2783223403 countsByYear W27832234032023 @default.
• W2783223403 crossrefType "journal-article" @default.
• W2783223403 hasAuthorship W2783223403A5005089552 @default.
• W2783223403 hasAuthorship W2783223403A5078926521 @default.
• W2783223403 hasAuthorship W2783223403A5084574856 @default.
• W2783223403 hasBestOaLocation W27832234031 @default.
• W2783223403 hasConcept C126322002 @default.
• W2783223403 hasConcept C141071460 @default.
• W2783223403 hasConcept C14184104 @default.
• W2783223403 hasConcept C197636746 @default.
• W2783223403 hasConcept C197934379 @default.
• W2783223403 hasConcept C2778063415 @default.
• W2783223403 hasConcept C2779034229 @default.
• W2783223403 hasConcept C2780580376 @default.
• W2783223403 hasConcept C2781112942 @default.
• W2783223403 hasConcept C71924100 @default.
• W2783223403 hasConceptScore W2783223403C126322002 @default.
• W2783223403 hasConceptScore W2783223403C141071460 @default.
• W2783223403 hasConceptScore W2783223403C14184104 @default.
• W2783223403 hasConceptScore W2783223403C197636746 @default.
• W2783223403 hasConceptScore W2783223403C197934379 @default.
• W2783223403 hasConceptScore W2783223403C2778063415 @default.
• W2783223403 hasConceptScore W2783223403C2779034229 @default.
• W2783223403 hasConceptScore W2783223403C2780580376 @default.
• W2783223403 hasConceptScore W2783223403C2781112942 @default.
• W2783223403 hasConceptScore W2783223403C71924100 @default.
• W2783223403 hasLocation W27832234031 @default.
• W2783223403 hasLocation W27832234032 @default.
• W2783223403 hasLocation W27832234033 @default.
• W2783223403 hasLocation W27832234034 @default.
• W2783223403 hasOpenAccess W2783223403 @default.
• W2783223403 hasPrimaryLocation W27832234031 @default.
• W2783223403 hasRelatedWork W1593472362 @default.
• W2783223403 hasRelatedWork W1967870627 @default.
• W2783223403 hasRelatedWork W2000217995 @default.
• W2783223403 hasRelatedWork W2050786902 @default.
• W2783223403 hasRelatedWork W2153954868 @default.
• W2783223403 hasRelatedWork W2160759330 @default.
• W2783223403 hasRelatedWork W2359879566 @default.
• W2783223403 hasRelatedWork W2809883609 @default.
• W2783223403 hasRelatedWork W3186589128 @default.
• W2783223403 hasRelatedWork W4248047185 @default.
• W2783223403 hasVolume "Volume 11" @default.
• W2783223403 isParatext "false" @default.
• W2783223403 isRetracted "false" @default.
• W2783223403 magId "2783223403" @default.
• W2783223403 workType "article" @default.